PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4326-4341
Author(s):
P. Wu and Y.-Z. Hu
UPA and PAI-1 Analysis from Fixed Tissues – New Perspectives for a Known Set of Predictive Markers
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4370-4377
Author(s):
K. Malinowsky, C. Bollner, S. Hipp, D. Berg, M. Schmitt and K. F. Becker
Cytosine Methyltransferases as Tumor Markers
Journal:
Current Genomics
Volume:
11
Page:
568-577
Author(s):
Athanasia Pavlopoulou and Sophia Kossida
PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4433-4447
Author(s):
M. Mazzoletti and M. Broggini
Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4462-4481
Author(s):
M. D. Mediavilla, E. J. Sanchez-Barcelo, D. X. Tan, L. Manchester and R. J. Reiter
Reversal of Multidrug Resistance by Natural Substances from Plants
Journal:
Current Topics in Medicinal Chemistry
Volume:
10
Page:
1757-1768
Author(s):
Q. Wang, K. Michalak, O. Wesolowska, J. Deli, P. Molnar, J. Hohmann, J. Molnar and H. Engi
Microsatellite Instability (MSI) as Genomic Marker in Endometrial Cancer: Toward Scientific Evidences
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
1356-1365
Author(s):
A. Tinelli, V. Mezzolla, G. Leo, M. Pisano, F. Storelli, G. Alemanno, A. Malvasi, S. Tommasi, G. Ronzino and V. Lorusso
Tubulin-Independent Tau in Alzheimer’s Disease and Cancer: Implications for Disease Pathogenesis and Treatment
Journal:
Current Alzheimer Research
Volume:
7
Page:
697-707
Author(s):
S. Souter and G. Lee
Drug Discovery in Ovarian Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
5
Page:
251-260
Author(s):
Dana M. Chase, Nidhee Mathur and Krishnansu S. Tewari
Regulation of Apoptosis and Cell Survival by Resveratrol
Journal:
Mini-Reviews in Organic Chemistry
Volume:
7
Page:
262-266
Author(s):
Simone Fulda